ProQuest Associates IV LLC

10% owner at EAGLE PHARMACEUTICALS, INC.; 10% owner at Immune Design Corp.

Sold, on record
$49.2M
Dollars the filings state
Form 4 sales
8
Latest Apr 25, 2017
Form 144 notices
0
Proposed sales
Companies
2
Filed as an executive or holder

Companies

Sales by reason

0
Routine
0
Plan not stated
0
No plan
0
Unusual
Stacked: routine sales under a plan, sales whose filing does not state a plan, sales with no plan, and unusual sales.

Form 4 sales per month, last 12 months.

Sales chart range

Sales by company

Shares sold, every Form 4 sale on record.

Timeline

  1. 1 Form 4 sale Immune Design Corp.Plan not stated
    Jul 29, 2014 2014

    Sold 208,334 shares at $12.00 ($2.5M)

    ProQuest Associates IV LLC, 10% owner

    Sold 8.3% of holdings ($30.2M position)2.3M shares leftFirst sale on recordFiling

  2. 2 Form 4 sale Immune Design Corp.Plan not stated
    Apr 1, 2015 +246 days

    Sold 62,454 shares at $26.37 ($1.6M)

    ProQuest Associates IV LLC, 10% owner

    Sold 2.6% of holdings ($63.7M position)2.4M shares leftFiling

  3. 3 Form 4 sale EAGLE PHARMACEUTICALS, INC.Plan not stated
    Sep 29, 2016 +547 days

    Sold 77,900 shares at $70.04 ($5.5M)

    ProQuest Associates IV LLC, 10% owner

    Sold 1.7% of holdings ($313M position)4.4M shares leftFirst sale on recordFiling

  4. 4 Form 4 sale EAGLE PHARMACEUTICALS, INC.Plan not stated
    Nov 4, 2016 +36 days

    Sold 245,770 shares at $71.02 ($17.5M)

    ProQuest Associates IV LLC, 10% owner

    Sold 5.6% of holdings ($314M position)4.2M shares leftFiling

  5. 5 Form 4 sale EAGLE PHARMACEUTICALS, INC.Plan not stated
    Nov 11, 2016 +7 days

    Sold 34,486 shares at $85.15 ($2.9M)

    ProQuest Associates IV LLC, 10% owner

    Sold 0.9% of holdings ($339M position)3.9M shares leftFiling

  6. 6 Form 4 sale EAGLE PHARMACEUTICALS, INC.Plan not stated
    Jan 4, 2017 +54 days

    Sold 65,114 shares at $85.16 ($5.5M)

    ProQuest Associates IV LLC, 10% owner

    Sold 1.7% of holdings ($336M position)3.9M shares left0.8x usual sizeFiling

  7. 7 Form 4 sale EAGLE PHARMACEUTICALS, INC.Unusual
    Mar 29, 2017 +84 days

    Sold 106,468 shares at $83.01 ($8.8M)

    ProQuest Associates IV LLC, 10% owner

    Sold 82.1% of holdings ($10.8M position)23,274 shares left1.5x usual sizeFiling

  8. 8 Form 4 sale EAGLE PHARMACEUTICALS, INC.Unusual
    Apr 25, 2017 +27 days

    Sold 54,180 shares at $88.38 ($4.8M)

    ProQuest Associates IV LLC, 10% owner

    Sold 88.9% of holdings ($5.4M position)6,777 shares left0.7x usual sizeFiling

Every transaction

Loading transactions…

Sales and notices (8)

Form 144 notices and Form 4 sales by ProQuest Associates IV LLC
Source
Apr 25, 2017Apr 27, 2017EAGLE PHARMACEUTICALS, INC.10% ownerForm 4 sale54,180$4.8M88.9%UnusualSEC
Mar 29, 2017Mar 29, 2017EAGLE PHARMACEUTICALS, INC.10% ownerForm 4 sale106,468$8.8M82.1%UnusualSEC
Jan 4, 2017Jan 6, 2017EAGLE PHARMACEUTICALS, INC.10% ownerForm 4 sale65,114$5.5M1.7%Plan not statedSEC
Nov 11, 2016Nov 14, 2016EAGLE PHARMACEUTICALS, INC.10% ownerForm 4 sale34,486$2.9M0.9%Plan not statedSEC
Nov 4, 2016Nov 4, 2016EAGLE PHARMACEUTICALS, INC.10% ownerForm 4 sale245,770$17.5M5.6%Plan not statedSEC
Sep 29, 2016Sep 30, 2016EAGLE PHARMACEUTICALS, INC.10% ownerForm 4 sale77,900$5.5M1.7%Plan not statedSEC
Apr 1, 2015Apr 2, 2015Immune Design Corp.10% ownerForm 4 sale62,454$1.6M2.6%Plan not statedSEC
Jul 29, 2014Jul 31, 2014Immune Design Corp.10% ownerForm 4 sale208,334$2.5M8.3%Plan not statedSEC